"NJRetina-Teaneck is an eye care center & ophthalmology clinic with retina specialists & vitreoretinal surgeons providing eye exams, diagnosis & treatment for retina diseases, problems & conditions including age related macular degeneration (AMD), macular diseases, diabetic retinopathy (DR), retinal vascular disease such as retinal vein occlusion & retinal artery occlusion, retinal detachment & tears, retinal membranes & macular holes. NJRetina specialists perform retina injections for AMD and Diabetic Retinopathy & laser photocoagulation treatment in our offices & a wide range of retina surgery including scleral buckle surgery, vitrectomy & pneumatic retinopexy for patients needing surgery to preserve or restore vision."

During the past decade, Retina Associates of NJ conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 10 clinical trials were completed, i.e. on average, 43.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 8 clinical trials were completed. i.e. 57.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Retina Associates of NJ" #1 sponsor was "Hoffmann-La Roche" with 10 trials, followed by "Kodiak Sciences Inc" with 5 trials sponsored, "Clearside Biomedical, Inc." with 2 trials sponsored, "ThromboGenics" with 2 trials sponsored and "Alimera Sciences" with 2 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Retina Associates of NJ" #1 collaborator was "AbbVie" with 1 trials as a collaborator, "Chugai Pharmaceutical" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator and "The Macula Foundation, Inc." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Retina Associates of NJ" are "Diabetic Macular Edema" (6 trials), "Geographic Atrophy" (3 trials), "Macular Edema" (3 trials), "Retinal Vein Occlusion" (3 trials) and "Diabetic Retinopathy" (2 trials). Many other conditions were trialed in "Retina Associates of NJ" in a lesser frequency.

Most popular intervention types in "Retina Associates of NJ" are "Drug" (29 trials), "Other" (11 trials), "Procedure" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Sham Procedure" (11 trials), "Aflibercept" (8 trials), "Faricimab" (5 trials), "KSI-301" (5 trials) and "IVT aflibercept" (2 trials). Other intervention names were less common.

The vast majority of trials in "Retina Associates of NJ" are 29 trials for "All" genders.

Currently, there are NaN active trials in "Retina Associates of NJ". undefined are not yet recruiting, 2 are recruiting, 9 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Retina Associates of NJ, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Retina Associates of NJ, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".